AIDS across Europe, 1994-98: the EuroSIDA study.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Lancet

• Publication date

  2000-07-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(00)02504-6PMID 11071184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opportunistic infections in the era of HAART.

  1999cited by this paper
• Risk of new AIDS diseases in people on triple therapy.

  1999cited by this paper
• Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?

  1999cited by this paper
• Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

  1999cited by this paper
• Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study

  1999cited by this paper
• AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.

  1999cited by this paper
• Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

  1999cited by this paper
• The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

  1998cited by this paper
• Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.

  1998cited by this paper
• The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection

  1998cited by this paper
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

  1998cited by this paper
• The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

  1998cited by this paper
• Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

  1998cited by this paper
• Opportunistic infections occurring during highly active antiretroviral treatment

  1998cited by this paper
• Changes in use of antiretroviral therapy in regions of Europe over time

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.

  1998cited by this paper
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group.

  1998cited by this paper
• A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

  1998cited by this paper
• Rapid Change in the Use of Antiretroviral Agents and Improvement in a Population of HIV-Infected Patients: France, 1995 to 1997

  1998cited by this paper
• Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

  1998cited by this paper
• Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

  1997cited by this paper
• Impact of protease inhibitors on AIDS‐defining events and hospitalizations in 10 French AIDS reference centres

  1997cited by this paper
• Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group.

  1997cited by this paper
• Changing incidence of AIDS‐defining illnesses in the era of antiretroviral combination therapy

  1997cited by this paper
• A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

  1997cited by this paper
• Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort

  1996cited by this paper
• Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses

  1995cited by this paper
• USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Introduction

  1995cited by this paper
• Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

  1995cited by this paper
• Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.

  1995cited by this paper
• Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study.

  1994cited by this paper
• Survival prognosis of HIV-infected patients.

  1993cited by this paper
• The AIDS-defining diagnosis and subsequent complications: a survival-based severity index.

  1991cited by this paper
• Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.

  1991cited by this paper
• Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.

  1991cited by this paper
• Serial CD4 lymphocyte counts and development of AIDS.

  1991cited by this paper

• British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024

  2024influential citation
• Cardiac Transplantation in HIV-Positive Patients: A Narrative Review

  2021cites this paper
• Cardiovascular computed tomography and HIV: The evolving role of imaging biomarkers in enhanced risk prediction

  2021cites this paper
• Uveitis and Allied Disorders

  2021cites this paper
• Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy.

  2021cites this paper
• 30 Jahre ART: Vom Todesurteil zur chronischen Erkrankung

  2020cites this paper
• Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report

  2020cites this paper
• The EuroSIDA study: 25 years of scientific achievements

  2019cites this paper
• Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative men who have sex with men (MSM) in Amsterdam.

  2019cites this paper
• Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting

  2018cites this paper
• Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy

  2018cites this paper
• Behandlung HPV-assoziierter analer Läsionen bei HIV-positiven Patienten – chirurgische Abtragung vs. topische Therapie mit Imiquimod

  2018cites this paper
• Mortalité et activation immunitaire chronique chez les personnes vivant avec le VIH naïves de traitement antirétroviral en Afrique de l’Ouest

  2018cites this paper
• Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review

  2017cites this paper
• Abstract Modelling Early Initiation of HAART to Forestall AIDS-related Lymphoma in South Africa : a Cost-Effectiveness Analysis

  2017cites this paper
• In-Patient Mortality among PLHIV: A 7-Year Hospital-Based Retrospective Study in Coastal South India

  2017cites this paper
• The changing face of bacteraemia in an HIV-1 positive cohort in the United Kingdom.

  2017cites this paper
• Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century

  2017cites this paper
• HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study

  2017cites this paper
• The characteristics of HIV serodiscordant couples consulted at the HIV Out-Patient Clinic in Warsaw

  2017cites this paper
• NON-HODGKIN LYMPHOMAS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME )

  2017influential citation
• Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis

  2017cites this paper
• Neuropathology of HIV-1 Disease

  2017cites this paper
• Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?

  2016cites this paper
• Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy

  2016cites this paper
• La conta dei linfociti nel monitoraggio del paziente con infezione da HIV: evidenze per un impiego ragionato@@@Is it time to change the timeline of lymphocyte T CD4+ count in clinical practice?

  2016cites this paper
• Epidemiology of fungal infections in HIV infected individuals in France : P jirovecii pneumonia and invasive aspergillosis in FHDH ANRS CO4

  2016influential citation
• Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals

  2016cites this paper
• Hepatitis B coinfection in HIV-positive patients starting antiretroviral therapy

  2016cites this paper
• Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

  2016cites this paper
• Pericardial effusion with Mycobacterium avium complex in HIV-infected patients

  2016cites this paper
• Efavirenz as component of initial combination antiretroviral therapy – Data from the Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group

  2016cites this paper
• Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

  2015cites this paper
• Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil

  2015cites this paper
• Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009

  2015cites this paper
• The HIV-1 transgenic rat model of neuroHIV.

  2015cites this paper
• HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies

  2015cites this paper
• Linfoma nasal de células T/NK

  2015influential citation
• Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent

  2015cites this paper
• Assessment of long-term safety and effectiveness of atazanavir (ATV) in the first antiretroviral treatment regimen in POLCA cohort

  2015cites this paper
• AIDS: Clinical Manifestations

  2014cites this paper
• The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan

  2014cites this paper
• [HIV in the lung from 1982 to 2013].

  2014cites this paper
• Insights from an individual-level model of HIV programmes in southern Africa : HIV testing, ART and resistance

  2014cites this paper
• New insights into immune reconstitution inflammatory syndrome of the central nervous system

  2014cites this paper
• Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era

  2014cites this paper
• Le poumon du VIH de 1982 à 2013

  2014influential citation
• Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study

  2014cites this paper
• Screening colonoscopy in HIV‐infected patients: high rates of mucosal abnormalities in a German HIV‐infected cohort

  2014cites this paper
• Hepatitis C virus infection in the human immunodeficiency virus infected patient.

  2014cites this paper
• HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort

  2014cites this paper
• Clinical care of HIV-patients: evaluating progress and future challenges

  2014cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2014

  2014cites this paper
• Factors associated with resolution and progression of HIV/hepatitis C virus infection.

  2014cites this paper
• Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries – a mini-review

  2014cites this paper
• Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic

  2014cites this paper
• Other Dementias

  2013cites this paper
• Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China

  2013cites this paper
• The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

  2013cites this paper
• Clinical review: Respiratory failure in HIV-infected patients - a changing picture

  2013cites this paper
• Pneumocystis pneumonia associated with human immunodeficiency virus.

  2013cites this paper
• A Review of the Extent of HIV Drug Resistance in Vietnam

  2013cites this paper
• HIV infection and hypertension: Epidemiological and pathogenetic aspects

  2013cites this paper
• The Incidence of AIDS-De fi ning Illnesses at a Current CD 4 Count ≥ 200 Cells / μ L in the Post – Combination Antiretroviral Therapy Era

  2013cites this paper
• Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults.

  2013cites this paper
• Therapy with Advanced Disease in the Asia-Pacific Region : Results from the TREAT Asia HIV Predictors of Clinical Progression in HIV-1-Infected Adults Initiating Combination Antiretroviral

  2013cites this paper
• Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review

  2013cites this paper
• 30 aastat HI-viiruse avastamisest

  2013cites this paper
• [Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].

  2013cites this paper
• HIV Associated Neurocognitive Disorders

  2013cites this paper
• HIV á Íslandi 1983-2012

  2013cites this paper
• TLR2-Activated B Cells are Phenotypically Similar to the Abnormal Circulating B Cells Seen Preceding the Diagnosis of AIDS-Related NHL Diagnosis

  2013cites this paper
• HIV-associated lymphomas Durable remissions with autologous stem cell transplantation for high risk

  2013cites this paper
• Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis.

  2013cites this paper
• TLR2 activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS related non-Hodgkin lymphoma (NHL) diagnosis

  2013cites this paper
• Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency

  2013cites this paper
• Predictors of Clinical Progression in HIV-1-Infected Adults Initiating Combination Antiretroviral Therapy with Advanced Disease in the Asia-Pacific Region

  2013cites this paper
• The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource‐limited setting

  2013cites this paper
• Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings

  2012cites this paper
• Role of delay differential equations in modelling low level HIV viral load

  2012cites this paper
• Viral Malignancies in HIV-Associated Immune Deficiency

  2012cites this paper
• HIV & AIDS in the North West of England 2011

  2012cites this paper
• The changing face of death in Trinidad and Tobago, before and after independence.

  2012cites this paper
• Surgical Complications in 275 Human Immunodeficiency Virus (HIV) Infected Liver and/or Kidney Transplant Recipients

  2012cites this paper
• Polyacrylamide Hydrogel Injection in the Management of Human Immunodeficiency Virus-Related Facial Lipoatrophy: Results of the LIPOPHILL Open-Label Study

  2012cites this paper
• Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience

  2012cites this paper
• The EBV-HIV interrelationship and the value of EBV-DNA analysis

  2012cites this paper
• The integration of independent national HIV surveillance datasets and application of statistical methods to enhance their public health utility

  2012cites this paper
• Early Determination of Human Immunodeficiency Virus Status by Routine Voluntary Counseling and Testing in Benin City, Nigeria

  2012cites this paper
• Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

  2012cites this paper
• Clinical implications of immune recovery during antiretroviral treatment for HIV infection

  2012cites this paper
• Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.

  2012cites this paper
• Elevated alanine aminotransferase in antiretroviral‐naïve HIV‐infected African patients: magnitude and risk factors

  2012cites this paper
• The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression

  2012cites this paper
• Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.

  2012cites this paper
• The Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction

  2012cites this paper
• Combination Therapy of AIDS

  2012cites this paper
• Impact of Chemotherapy on Immunological Parameters inHIV associated Malignancies

  2011cites this paper
• A Study on Thyroid Dysfunction in HIV Infected Individuals

  2011cites this paper
• Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998–2008

  2011cites this paper